BioCentury
ARTICLE | Company News

SkyePharma signs two deals with Meditech

January 17, 2001 8:00 AM UTC

Meditech Research (West Perth, Australia) received from SkyePharma (LSE:SKP; SKYE) an exclusive license to commercialize Solaraze diclofenac gel to treat actinic keratoses in Australia, New Zealand, M...